Rapid Dose Therapeutics Corp. (CSE: DOSE)
Canada
· Delayed Price · Currency is CAD 0.150
0.00 (0.00%)
Sep 24, 2024, 9:30 AM EDT
Rapid Dose Therapeutics Revenue
Rapid Dose Therapeutics had revenue of 398.99K CAD in the quarter ending May 31, 2024, with 65.70% growth. This brings the company's revenue in the last twelve months to 1.18M, up 31.35% year-over-year. In the fiscal year ending February 29, 2024, Rapid Dose Therapeutics had annual revenue of 1.02M with 42.06% growth.
Revenue (ttm)
1.18M
Revenue Growth
+31.35%
P/S Ratio
13.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
18.70M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries Inc. | 1.52B |
| Trulieve Cannabis Corp. | 1.59B |
| Cresco Labs Inc. | 1.01B |
| Planet 13 Holdings Inc. | 139.22M |
| Ayr Wellness Inc. | 635.84M |
| Grown Rogue International Inc. | 28.83M |
| Jushi Holdings Inc. | 360.23M |
| iAnthus Capital Holdings, Inc. | 229.29M |